Electrolyte replacement: Difference between revisions
Jump to navigation
Jump to search
NCLEX nursing pharmacology monographs — batch import |
Add medication infobox (Drugbox) to monographs |
||
| Line 1: | Line 1: | ||
{{Drugbox | |||
| name = Electrolyte replacement | |||
| therapeutic = Electrolyte replacement | |||
| pharmacologic = Electrolyte salts | |||
| onset = Oral slower; IV faster (must be controlled). | |||
| halflife = Targeted to normal serum ranges. | |||
| routes = IV | |||
| highalert = <span style="color:#b00020;">'''Yes'''</span> (IV potassium chloride and IV magnesium) | |||
| blackbox = None | |||
| antidote = Calcium for magnesium toxicity; insulin and dextrose and other measures for hyperkalemia. | |||
| pregnancy = Used as needed. | |||
}} | |||
<div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;"> | <div style="border-left:4px solid #3f6f5b;background:#f3f6f4;padding:8px 12px;margin-bottom:12px;font-size:0.95em;"> | ||
''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.'' | ''Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and '''must be verified against current manufacturer labeling before clinical use'''. This is educational content, not prescribing guidance.'' | ||
Latest revision as of 16:09, 17 June 2026
| Drug monograph · NCLEX study reference | |
| Therapeutic class | Electrolyte replacement |
|---|---|
| Pharmacologic class | Electrolyte salts |
| Onset / peak / duration | Oral slower; IV faster (must be controlled). |
| Half-life / level | Targeted to normal serum ranges. |
| Routes | IV |
| High-alert (ISMP) | Yes (IV potassium chloride and IV magnesium) |
| Black box warning | None |
| Antidote / reversal | Calcium for magnesium toxicity; insulin and dextrose and other measures for hyperkalemia. |
| Pregnancy / lactation | Used as needed. |
Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.
Electrolyte replacement — Electrolyte replacement; Electrolyte salts.
Identification
- Therapeutic class: Electrolyte replacement.
- Pharmacologic class: Electrolyte salts.
Pharmacology
- Mechanism of action: Replace deficient electrolytes to restore normal physiology.
- Onset / peak / duration: Oral slower; IV faster (must be controlled).
- Half-life / therapeutic level: Targeted to normal serum ranges.
Clinical use
- Indications: Hypokalemia (potassium), hypomagnesemia (magnesium), hypocalcemia and emergencies (calcium), acidosis (bicarbonate), hypophosphatemia (phosphate).
- Usual dose, route, frequency: Oral or IV; IV potassium always diluted and infused slowly via a pump.
- Maximum dose / adjustments: IV potassium never given by IV push and not faster than about 10 mEq/hr peripherally; adjust for renal function.
Safety
- Contraindications: Potassium in hyperkalemia or significant renal failure; calcium with caution in digoxin toxicity.
- Black box warning: None.
- Interactions: Potassium with ACE inhibitors, ARBs, potassium-sparing diuretics, and salt substitutes (hyperkalemia).
- Pregnancy / lactation: Used as needed.
- High-alert: Yes (IV potassium chloride and IV magnesium).
Adverse effects
- Common side effects: Oral potassium GI upset; infusion-site burning with IV potassium.
- Serious effects to report: Cardiac arrhythmias from too-fast potassium or hyperkalemia, magnesium toxicity (loss of reflexes, respiratory depression), calcium extravasation.
- Antidote / reversal: Calcium for magnesium toxicity; insulin and dextrose and other measures for hyperkalemia.
Nursing process
- Assessment before administration: Serum level, renal function, ECG, urine output, IV site.
- Interventions during therapy: Always dilute IV potassium and use a pump (never push); monitor ECG; give oral potassium with food and full water; check renal function and urine output first.
- Monitor: Serum electrolytes, ECG, renal function, IV site, reflexes (magnesium).
- Evaluation / expected outcome: Corrected electrolyte level.
Patient teaching
- Patient teaching: Take oral potassium with food and a full glass of water; do not crush extended-release potassium; report palpitations.
- Notify provider if: Palpitations, muscle weakness, IV-site pain, decreased urination.
- Administration tips: IV potassium always diluted and pumped, never pushed; high-alert double-check.